#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prodromal Alzheimer's disease Penile squamous cell carcinoma Testicular leiomyosarcoma Diffuse large B-cell lymphoma refractory Rheumatoid arthritis Macular telangiectasia Haemophilia B without inhibitors Spinal muscular atrophy X-linked lymphoproliferative syndrome Retinopathy of prematurity Malignant neoplasm of choroid Marginal zone lymphoma recurrent Brain stem glioma B-cell small lymphocytic lymphoma refractory Stress cardiomyopathy More trials…

    Learn about Rare Diseases

    Lymphangioma – Basic Information Bronchopulmonary dysplasia Thrombotic thrombocytopenic purpura – Basic Information Pemphigus – Diagnostics Nephroblastoma – Life with Disease Behcet’s syndrome – Life with Disease Focal segmental glomerulosclerosis – Basic Information Pleural mesothelioma malignant – Life with Disease Glomerulonephritis membranous – Diagnostics Angiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ruxotemitide Lib-01 Monohydrate Bemnifosbuvir Hemisulfate Cyanocobalamin Lufepirsen Ampicillin Sodium Pivekimab Sunirine Mifepristone Fosinopril Sodium Paroxetine Hydrochloride Iopromide Interleukin-1 Exl01 Fidanacogene Elaparvovec Imiquimod Pyridoxine VIPOGLANSTAT Evolocumab Calcium Lactate Gluconate Lasmiditan More therapies…

    Learn about Your Condition

    Osteonecrosis of jaw Extraskeletal ossification Niemann-Pick disease Portal hypertension Cervix carcinoma stage IV Thymoma Postoperative delirium Spina bifida Retroperitoneal cancer Chronic hepatic failure Metachromatic leukodystrophy Neonatal respiratory failure B-cell type acute leukaemia Aortic disorder Epileptic encephalopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clinique Victor Hugo

Clinique Victor Hugo

Centre De Cancerologie De La Sarthe, 64 Rue De Degre, Le Mans, 72000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Talazoparib
    • Enzalutamide
    Belgium Bulgaria Czechia Finland France Germany +6

  • Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Pirtobrutinib
    • Rituximab
    • Venetoclax
    Belgium Czechia Denmark France Germany Hungary +5

  • Study Comparing Sacituzumab Govitecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Docetaxel
    • Sacituzumab Govitecan
    Austria Belgium France Germany Greece Italy +4

  • Study of Venetoclax and Low Dose Cytarabine for Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Cytarabine
    • Venetoclax
    France

  • Study on Stereotactic Body Radiation Therapy with or without Durvalumab for Patients with Oligometastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Durvalumab
    France

  • Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Goserelin
    • Letrozole
    Austria Belgium France Germany Hungary Ireland +4

  • Study on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Laryngeal squamous cell carcinoma
    • Squamous cell carcinoma of the hypopharynx
    Investigated Drugs:
    • Cisplatin
    • Docetaxel
    • Fluorouracil
    France

  • Study on the Effects of Samuraciclib and Elacestrant for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Elacestrant
    • Samuraciclib
    France Spain

  • Study of Lorigerlimab and Docetaxel for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Prostate cancer
    Investigated Drugs:
    • Igg4 Tetravalent Bispecific Antibody-Like Protein Against Pd-1 And Ctla4
    • Dexamethasone
    • Docetaxel
    Belgium Bulgaria France Poland Spain

  • Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Doxorubicin
    • Paclitaxel
    • Pembrolizumab
    Belgium France Germany Hungary Ireland Poland +2
Previous Page
1 … 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!